The stock market rebounded on Friday with the gains nearly giving the bulls the weekly win. However, the bears did just enough damage throughout the week to get their first overall victory in five weeks. The rally was enough to lift the small-caps to a weekly gain with the S&P 500 setting a fresh all-time intraday peak in the process. Volatility also settled lower and below a key level of...
Continue reading >>Oversold, OCGN is gaining momentum. According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100% success against severe cases of the disease. COVAXIN...
Continue reading >>The stock market rebounded on Friday with the gains nearly giving the bulls the weekly win. However, the bears did just enough damage throughout the week to get their first overall victory in five weeks. The rally was enough to lift the small-caps to a weekly gain with the S&P 500 setting a fresh all-time intraday peak in the process. Volatility also settled lower and below a key level of...
Continue reading >>...
Continue reading >>The stock market rebounded on Friday with the gains nearly giving the bulls the weekly win. However, the bears did just enough damage throughout the week to get their first overall victory in five weeks. The rally was enough to lift the small-caps to a weekly gain with the S&P 500 setting a fresh all-time intraday peak in the process. Volatility also settled lower and below a key level of...
Continue reading >>...
Continue reading >>